Medicare4U Ltd –young and fast developing UK medical facilitator with focus on Eastern Europe signs memorandum of understanding and partnership with Future Health UK, a Nottingham based BIOBANK and global leader in the collection and storage of human blood and tissue.
Future Health BIOBANK have the finest experts, the latest technology and an active presence in 50 countries around the world. As the company seeks to expand in Europe Future Health is promoting its unique services through the partners with knowledge of local markets such as Medicare4U. Medicare4U will promote services and products of Future Health through network of its partners, healthcare providers such as Kiev Heart Center, ISIDA, 32Dent and others. The main focus for Future Health In Eastern Europe will be Romania, Moldova and Ukraine where markets potential immensive for cord blood collection and storage, stem cell research. Lately Future Health has developed a few absolutely new services which are new not only for Eastern Europe market. Collection of T Cells, Lipo Cells and Tooth Cells are the services which were not present on the European market so far and now will be available with the help of Future Health advisory Board, which includes some of the most highly qualified and respected experts in the field of Immunogenetics, Transplantation Biology, Disease Mechanisms, Cell Biology, Chemical Pathology, Haematology, Gynaecology and Metabolic Medicines.
Medicare4U will be promoting Future Health services in Ukraine during 2012-2014. This partnership is to make an easy access to preme care and medicine science for Eastern Europian citizens.
Medicare4U and Future Health development program aims to provide better coordination of services for clients and patients and offer education, support and resources designed to support yuong couples looking for cord blood storage, patients with immune abd chronic health conditions better manage their disease and improve their health status over time.
“We are very enthusiastic about this new partnership and the opportunity it provides Future Health and Medicare4U to better meet the needs of our patients in Eastern Europe and surrounding countries and ensure adequate and timely access to primary and preventive health care with latest stem cell technologies,” said regional director of Future Health Yannis Karispiadis. “We also are gratified to be playing a positive role in the development of the Medicare4U projects and hope that our presence as a major player in this region can also give an easy access to stem cell storage, usage and research reports.”
